Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This meta-analysis concluded that compound glycyrrhizin combined with conventional treatments enhanced hair regrowth in alopecia areata patients, though it was associated with some mild adverse effects like oedema.

This article hypothesizes that apremilast, a phosphodiesterase 4 inhibitor, could be a targeted treatment for alopecia areata due to its ability to suppress interferon-gamma production, but reports no new clinical results.

This report describes a rare scalp condition in children with features similar to tinea capitis but shows negative fungal cultures, and suggests possible slow improvement with griseofulvin in two cases.

This entry contains no research abstract, so no scientific findings or conclusions are reported.

This study observed that trichoscopy can identify specific patterns in alopecia areata, such as white and black dots, which assists in non-invasive diagnosis and assessing disease severity.

This review discusses primary neutrophilic cicatricial alopecias, their clinical and histological characteristics, and the importance of early therapeutic intervention to prevent scarring alopecia, reporting no new clinical results.

This study reported rapid hair regrowth in a patient with early-stage alopecia areata after treatment with intralesional triamcinolone acetonide, prednisone, minoxidil, and vitamin C, leading to complete recovery of the bald area within three months.

In this study, researchers demonstrated that using cyanoacrylate glue effectively reduces microbial contamination in biopsy samples from the skin surface of wild roe deer, offering valuable insights for human hair follicle microbiome research despite the nonhuman model.

This case report suggests that in African-American patients, the histology of Central Centrifugal Cicatricial Alopecia may resemble lichen planopilaris, indicating a potential diagnostic challenge.

ACTH promotes hair growth in mink, but α-MSH does not.

This paper reports on five cases of alopecia areata in children and emphasizes the importance of understanding its characteristics for accurate diagnosis in pediatric patients.

In this study, researchers used a mouse model of alopecia areata to demonstrate that both ruxolitinib and baricitinib, oral JAK inhibitors, reduced hair loss, CD8+ cell infiltration, and expression of disease-related markers, with baricitinib showing greater effectiveness.

This article discusses the symptoms, diagnostic methods, and complications associated with achalasia and reports no new clinical findings.

This source reviews alopecia areata, highlighting its epidemiology, immune-related causes, diagnostic methods, and the shift in treatment with JAK inhibitors like baricitinib and ritlecitinib, marking the first disease-modifying options for this hair loss condition.

This study reported that while Intralesional Triamcinolone Acetonide injections effectively improved mouth opening in patients with Oral Submucous Fibrosis, it also led to symptoms of Cushing's Syndrome, highlighting the need for careful monitoring of adverse effects.

In this study, researchers observed that phospholipid-calcium carbonate hybrid nanoparticles effectively delivered Tofacitinib citrate topically, which significantly inhibited hair follicle apoptosis and promoted hair growth in a mouse model of chemotherapy-induced alopecia, compared to a traditional Tofacitinib solution.

This review outlines acne management strategies for individuals with polycystic ovary syndrome, but reports no new clinical results.

In this study, both intralesional and microneedling treatments with triamcinolone acetonide significantly reduced alopecia areata markers, but their clinical responses did not differ significantly, suggesting microneedling as a safe, cost-effective option with minimal complications.

This study reported a rare case where a pheochromocytoma produced ACTH, leading to cyclic Cushing syndrome, and underscores the importance of considering this possibility in cases of ACTH-dependent hypercortisolism with an adrenal mass.

This study found that androsterone glucuronate (ADT-G) was the only androgenic metabolite sensitive to detecting differences between adult women with acne and controls, and its levels decreased with systemic treatment.

This article describes a rare case of alopecia with both scarring and non-scarring features, combining histologic signs of central centrifugal cicatricial alopecia with select immunologic features of alopecia areata.

This study investigated alkaline phosphatase activity in scalp biopsies from patients with alopecia areata and totalis, but provides no new conclusive clinical results.

This review discusses the pathogenesis and diagnosis of alopecia and acne, emphasizing the need for coordinated treatment approaches in conditions like FPHL/AGA and complex acne, but reports no new clinical results.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

This case report highlights two instances of alopecia areata, demonstrating diverse presentations, and suggests upadacitinib as a promising treatment option, resulting in hair regrowth within 3–6 months, without worsening sarcoidosis-related skin lesions.

This article reviews the characteristics and presentation of fibrosing alopecia in a pattern distribution, a form of scarring alopecia similar to androgenetic alopecia and lichen planopilaris, but provides no new clinical findings.

In this study, the researchers discovered that specific polyamine depletion enhances stemness in hair follicle stem cells through a mechanism independent of mRNA translation.

In this study, intralesional triamcinolone acetonide injections were associated with halting the progression of frontal fibrosing alopecia in female patients and showed minimal adverse effects, but the efficacy as sole therapy remains unclear pending further trials.

This study developed a sensitive HPLC-MS/MS method for determining cyproterone acetate levels in human plasma and found no significant difference in its concentration between two oral formulations in bioequivalence testing.

This article discusses treatments for androgenic manifestations using cyproterone acetate alone or with estrogens, but it does not provide new clinical results.